Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Newbury Street Acquisition | NBST | Nov 22, 2024 | 10.93 | 0.00 |
Newbury Street Acquisition Unit | NBSTU | Nov 22, 2024 | 10.87 | 0.00 |
Newbury Street II Acquisition Unit | NTWOU | Nov 22, 2024 | 9.96 | 0.00 |
Newegg Commerce | NEGG | Nov 22, 2024 | 0.58 | +2.61 |
Newell Brands | NWL | Nov 22, 2024 | 9.12 | +2.01 |
NewGenIvf Group | NIVF | Nov 22, 2024 | 0.51 | -6.30 |
NewJersey Resources | NJR | Nov 22, 2024 | 51.04 | +2.39 |
Newmark Group A | NMRK | Nov 22, 2024 | 15.28 | +2.14 |
NewMarket | NEU | Nov 22, 2024 | 542.65 | +1.18 |
Newmont | NEM | Nov 22, 2024 | 43.38 | +0.14 |
Newpark Resources | NR | Nov 22, 2024 | 7.92 | +1.93 |
News A | NWSA | Nov 22, 2024 | 29.49 | -0.17 |
News B | NWS | Nov 22, 2024 | 32.06 | -0.16 |
NewtekOne | NEWT | Nov 22, 2024 | 14.53 | +3.20 |
Nexa Resources | NEXA | Nov 22, 2024 | 7.60 | -0.26 |
Nexalin Technology | NXL | Nov 22, 2024 | 3.82 | -2.05 |
NexGel | NXGL | Nov 22, 2024 | 3.32 | +1.53 |
NexGen | NXE | Nov 22, 2024 | 8.88 | +1.72 |
NexImmune | NEXI | Nov 22, 2024 | 2.31 | 0.00 |
NexPoint Diversified Real Estate Trust Pref | NXDT-A | Nov 22, 2024 | 16.18 | +0.03 |
Nexpoint Diversified REIT | NXDT | Nov 22, 2024 | 5.47 | +5.19 |
Nexpoint Real Estate Finance | NREF | Nov 22, 2024 | 17.11 | +0.47 |
NexPoint Real Estate Finance A | NREF-A | Nov 22, 2024 | 23.25 | -1.36 |
Nexpoint Residential Trust | NXRT | Nov 22, 2024 | 46.48 | +0.65 |
Nexstar Media Group A | NXST | Nov 22, 2024 | 169.75 | +0.37 |
Next Technology | NXTT | Nov 22, 2024 | 2.40 | +3.90 |
NextCure | NXTC | Nov 22, 2024 | 1.19 | -7.75 |
NextDecade | NEXT | Nov 22, 2024 | 7.48 | +2.61 |
Nextdoor | KIND | Nov 22, 2024 | 2.57 | +4.05 |
NextEra Energy | NEE | Nov 22, 2024 | 76.00 | -1.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.